Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia.
作者信息
Cruz Nicole M, Sugita Mayumi, Ewing-Crystal Nathan, Lam Linda, Galetto Roman, Gouble Agnes, Smith Julianne, Hassane Duane C, Roboz Gail J, Guzman Monica L
机构信息
a Division of Hematology and Oncology, Department of Medicine , Weill Cornell Medical College , New York , NY , USA.
b Cellectis SA , Paris , France.
出版信息
Leuk Lymphoma. 2018 Apr;59(4):978-982. doi: 10.1080/10428194.2017.1361023. Epub 2017 Aug 10.
Abstract
摘要
相似文献
1
Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia.抗体克隆的选择和鉴定对于基于流式细胞术准确监测急性髓系白血病中的CD123至关重要。
Leuk Lymphoma. 2018 Apr;59(4):978-982. doi: 10.1080/10428194.2017.1361023. Epub 2017 Aug 10.
2
Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia.开发一种新型全人源抗 CD123 抗体，以靶向治疗急性髓系白血病。
Leuk Res. 2019 Sep;84:106178. doi: 10.1016/j.leukres.2019.106178. Epub 2019 Jun 27.
3
CD123 bi-specific antibodies in development in AML: What do we know so far?在 AML 中开发的 CD123 双特异性抗体：目前我们了解多少？
Best Pract Res Clin Haematol. 2020 Dec;33(4):101219. doi: 10.1016/j.beha.2020.101219. Epub 2020 Nov 6.
4
Cytotoxicity Assessment and Apoptosis-related Gene Profiling of Antibody Treated Acute Myeloid Leukemia (AML) and Acute Lymphocytic Leukemia (ALL) Cancerous Cell Lines.抗体处理的急性髓性白血病（AML）和急性淋巴细胞白血病（ALL）癌细胞系的细胞毒性评估及凋亡相关基因谱分析
Iran J Allergy Asthma Immunol. 2019 Oct 30;18(6):679-687. doi: 10.18502/ijaai.v18i6.2181.
5
Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes.在遗传定义的急性髓系白血病亚型中表达假定的白血病干细胞靶标。
Leuk Res. 2020 Dec;99:106477. doi: 10.1016/j.leukres.2020.106477. Epub 2020 Nov 10.
6
CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.846 例急性白血病患者基于标准化免疫表型的 CD123 表达水平。
Cytometry B Clin Cytom. 2019 Mar;96(2):134-142. doi: 10.1002/cyto.b.21745. Epub 2018 Nov 18.
7
Soluble Expression and Characterization of a New scFv Directed to Human CD123.一种针对人CD123的新型单链抗体片段的可溶性表达与特性分析
Appl Biochem Biotechnol. 2016 Apr;178(7):1390-406. doi: 10.1007/s12010-015-1954-y. Epub 2016 Jan 9.
8
Development of a new anti-CD123 monoclonal antibody to target the human CD123 antigen as an acute myeloid leukemia cancer stem cell biomarker.开发一种新型抗CD123单克隆抗体，以靶向人类CD123抗原作为急性髓系白血病癌症干细胞生物标志物。
Biotechnol Appl Biochem. 2018 Nov;65(6):841-847. doi: 10.1002/bab.1681. Epub 2018 Aug 30.
9
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.CD123表达与儿童急性髓系白血病的高危疾病特征相关：来自儿童肿瘤协作组的报告
J Clin Oncol. 2022 Jan 20;40(3):252-261. doi: 10.1200/JCO.21.01595. Epub 2021 Dec 2.
10
Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.SL-101，一种新型抗 CD123 抗体偶联药物，在急性髓系白血病中的抗白血病疗效和作用机制。
Clin Cancer Res. 2017 Jul 1;23(13):3385-3395. doi: 10.1158/1078-0432.CCR-16-1904. Epub 2017 Jan 17.
引用本文的文献
1
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm.靶向CD123和CD303的免疫疗法：治疗母细胞样浆细胞样树突状细胞瘤的新前沿。
Int J Mol Sci. 2025 Mar 18;26(6):2732. doi: 10.3390/ijms26062732.
2
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123.由于精准靶向 CD123，在原始浆细胞样树突细胞肿瘤癌症治疗方面取得突破。
Int J Mol Sci. 2024 Jan 25;25(3):1454. doi: 10.3390/ijms25031454.
3
A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges.急性髓系白血病免疫治疗的前景：当前进展与挑战
Front Pharmacol. 2023 Apr 19;14:1151032. doi: 10.3389/fphar.2023.1151032. eCollection 2023.
4
Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.急性髓系白血病的免疫治疗干预措施
Cancer Treat Res. 2022;183:225-254. doi: 10.1007/978-3-030-96376-7_8.
5
Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia.靶向急性髓系白血病中 CD123 的同种异体 TCRαβ 缺陷嵌合抗原受体 T 细胞。
Nat Commun. 2022 Apr 28;13(1):2227. doi: 10.1038/s41467-022-29668-9.
6
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm.批准 tagraxofusp-erzs 用于治疗原始浆细胞样树突状细胞瘤。
Blood Adv. 2020 Aug 25;4(16):4020-4027. doi: 10.1182/bloodadvances.2019000173.
7
'Off-the-shelf' allogeneic CAR T cells: development and challenges.现成的异体嵌合抗原受体 T 细胞：开发与挑战。
Nat Rev Drug Discov. 2020 Mar;19(3):185-199. doi: 10.1038/s41573-019-0051-2. Epub 2020 Jan 3.
本文引用的文献
1
T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia.表达CD123嵌合抗原受体的T细胞用于治疗急性髓系白血病。
Curr Opin Hematol. 2015 Nov;22(6):484-8. doi: 10.1097/MOH.0000000000000190.
2
Acute Myeloid Leukemia.急性髓系白血病
N Engl J Med. 2015 Sep 17;373(12):1136-52. doi: 10.1056/NEJMra1406184.
3
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.靶向急性髓系白血病干细胞：综述及临床试验开发原则
Haematologica. 2014 Aug;99(8):1277-84. doi: 10.3324/haematol.2013.085209.
4
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.白细胞介素-3受体α链是人类急性髓性白血病干细胞的独特标志物。
Leukemia. 2000 Oct;14(10):1777-84. doi: 10.1038/sj.leu.2401903.
Zotero 插件